Format
Sort by
    Items per page

    Send to

    Choose Destination

    Links from PubMed

    Items: 1 to 20 of 102

    1.

    Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancer.

    Chen Z, Liu Z, Li W, Qu K, Deng X, Varma MG, Fichera A, Pigazzi A, Garcia-Aguilar J.

    Genes Chromosomes Cancer. 2011 Sep;50(9):689-99. doi: 10.1002/gcc.20891. Epub 2011 May 16.

    2.

    Chromosomal copy number alterations are associated with persistent lymph node metastasis after chemoradiation in locally advanced rectal cancer.

    Chen Z, Liu Z, Deng X, Warden C, Li W, Garcia-Aguilar J.

    Dis Colon Rectum. 2012 Jun;55(6):677-85. doi: 10.1097/DCR.0b013e31824f873f.

    3.

    Genomic changes in rectal adenocarcinoma associated with liver metastasis.

    Zhou HT, Shi ZZ, Zhou ZX, Jiang YY, Hao JJ, Zhang TT, Shi F, Xu X, Wang MR, Zhang Y.

    Cancer Biomark. 2013;13(4):281-8. doi: 10.3233/CBM-130351.

    PMID:
    24240589
    4.

    Genomic profiling of rectal adenoma and carcinoma by array-based comparative genomic hybridization.

    Shi ZZ, Zhang YM, Shang L, Hao JJ, Zhang TT, Wang BS, Liang JW, Chen X, Zhang Y, Wang GQ, Wang MR, Zhang Y.

    BMC Med Genomics. 2012 Nov 16;5:52. doi: 10.1186/1755-8794-5-52.

    5.

    Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer.

    Russo AL, Ryan DP, Borger DR, Wo JY, Szymonifka J, Liang WY, Kwak EL, Blaszkowsky LS, Clark JW, Allen JN, Zhu AX, Berger DL, Cusack JC, Mamon HJ, Haigis KM, Hong TS.

    J Gastrointest Cancer. 2014 Mar;45(1):34-9. doi: 10.1007/s12029-013-9546-y.

    6.

    Copy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-Type.

    Jin DH, Park SE, Lee J, Kim KM, Kim S, Kim DH, Park J.

    PLoS One. 2015 Sep 11;10(9):e0137657. doi: 10.1371/journal.pone.0137657. eCollection 2015.

    7.

    CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.

    Wallin U, Rothenberger D, Lowry A, Luepker R, Mellgren A.

    Dis Colon Rectum. 2013 Jul;56(7):859-68. doi: 10.1097/DCR.0b013e31828e5a72.

    PMID:
    23739192
    8.

    Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study.

    Molinari C, Ballardini M, Teodorani N, Giannini M, Zoli W, Emiliani E, Lucci E, Passardi A, Rosetti P, Saragoni L, Guidoboni M, Amadori D, Calistri D.

    Radiat Oncol. 2011 Nov 18;6:161. doi: 10.1186/1748-717X-6-161.

    9.

    Gene expression profile is associated with chemoradiation resistance in rectal cancer.

    Gantt GA, Chen Y, Dejulius K, Mace AG, Barnholtz-Sloan J, Kalady MF.

    Colorectal Dis. 2014 Jan;16(1):57-66. doi: 10.1111/codi.12395.

    PMID:
    24034224
    10.

    Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?

    Hur H, Kim NK, Min BS, Baik SH, Lee KY, Koom WS, Ahn JB, Kim H.

    Dis Colon Rectum. 2014 May;57(5):592-601. doi: 10.1097/DCR.0000000000000109.

    PMID:
    24819099
    11.

    Analysis of genomic aberrations associated with the clinicopathological parameters of rectal cancer by array‑based comparative genomic hybridization.

    Liang JW, Shi ZZ, Zhang TT, Hao JJ, Wang Z, Wang XM, Yang H, Wang MR, Zhou ZX, Zhang Y.

    Oncol Rep. 2013 May;29(5):1827-34. doi: 10.3892/or.2013.2296. Epub 2013 Feb 21.

    PMID:
    23440507
    12.

    Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer.

    Buijsen J, van Stiphout RG, Menheere PP, Lammering G, Lambin P.

    Radiother Oncol. 2014 May;111(2):237-42. doi: 10.1016/j.radonc.2014.03.006. Epub 2014 Apr 16.

    PMID:
    24746569
    13.

    Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.

    Tan BR, Thomas F, Myerson RJ, Zehnbauer B, Trinkaus K, Malyapa RS, Mutch MG, Abbey EE, Alyasiry A, Fleshman JW, McLeod HL.

    J Clin Oncol. 2011 Mar 1;29(7):875-83. doi: 10.1200/JCO.2010.32.3212. Epub 2011 Jan 4.

    14.

    p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.

    Luna-Perez P, Arriola EL, Cuadra Y, Alvarado I, Quintero A.

    Ann Surg Oncol. 1998 Apr-May;5(3):203-8.

    PMID:
    9607618
    15.

    Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: do we have indications for individual risk stratification?

    Sprenger T, Rothe H, Jung K, Christiansen H, Conradi LC, Ghadimi BM, Becker H, Liersch T.

    World J Surg Oncol. 2010 Apr 13;8:27. doi: 10.1186/1477-7819-8-27.

    16.

    Chromosomal instability portends superior response of rectal adenocarcinoma to chemoradiation therapy.

    Zaki BI, Suriawinata AA, Eastman AR, Garner KM, Bakhoum SF.

    Cancer. 2014 Jun 1;120(11):1733-42. doi: 10.1002/cncr.28656. Epub 2014 Mar 6.

    17.

    Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies.

    Belluco C, De Paoli A, Canzonieri V, Sigon R, Fornasarig M, Buonadonna A, Boz G, Innocente R, Perin T, Cossaro M, Polesel J, De Marchi F.

    Ann Surg Oncol. 2011 Dec;18(13):3686-93. doi: 10.1245/s10434-011-1822-0. Epub 2011 Jun 21.

    18.

    Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.

    Agostini M, Pucciarelli S, Enzo MV, Del Bianco P, Briarava M, Bedin C, Maretto I, Friso ML, Lonardi S, Mescoli C, Toppan P, Urso E, Nitti D.

    Ann Surg Oncol. 2011 Sep;18(9):2461-8. doi: 10.1245/s10434-011-1638-y. Epub 2011 Mar 17.

    PMID:
    21416156
    19.

    NPTX2 is associated with neoadjuvant therapy response in rectal cancer.

    Karagkounis G, Thai L, DeVecchio J, Gantt GA, Duraes L, Pai RK, Kalady MF.

    J Surg Res. 2016 May 1;202(1):112-7. doi: 10.1016/j.jss.2015.12.042. Epub 2015 Dec 30.

    PMID:
    27083956
    20.

    18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer.

    Hur H, Kim NK, Yun M, Min BS, Lee KY, Keum KC, Ahn JB, Kim H.

    J Surg Oncol. 2011 Jan 1;103(1):17-24. doi: 10.1002/jso.21736.

    PMID:
    20886551

    Supplemental Content

    Support Center